Exhibit 32(a)


            CERTIFICATION OF CHIEF EXECUTIVE OFFICER
               PURSUANT TO 18 U.S.C. SECTION 1350,
                     AS ADOPTED PURSUANT TO
          SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

      In  connection  with  the  IGENE Biotechnology,  Inc.  (the
"Company") Quarterly Report on Form 10-QSB/A for the period ended
June  30,  2004,  as  filed  with  the  Securities  and  Exchange
Commission on the date hereof (the "Report"), I, Stephen F.  Hiu,
President  of the Company, certify pursuant to 18 U.S.C.  Section
1350,  as  adopted pursuant to Section 906 of the  Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge:

     (1). The  Report  fully  complies  with  the requirements of
          Section  13(a) or 15(d) of the Securities Exchange  Act
          of 1934, as amended; and

     (2). The   information   contained   in  the  Report  fairly
          presents,  in  all  material  respects,  the  financial
          condition and results of operations of the Company.


Date: September 28, 2005                By: /s/ STEPHEN F. HIU
                                            _____________________
                                                STEPHEN F. HIU
                                                President


A signed original of this written statement required by Section
906 has been provided to the Company and will be retained by the
Company and furnished to the Securities and Exchange Commission
or its staff upon request.